(Q41251189)

28 September 2017

Searching for new TNF-alpha analogs having potential application in cancer therapy (English)

1 reference

28 September 2017

0 references

Menart V

1

1 reference

28 September 2017

Kus B

2

1 reference

28 September 2017

Novaković S

3

1 reference

28 September 2017

Sersa G

4

1 reference

28 September 2017

Gaberc-Porekar V

5

1 reference

28 September 2017

Harb V

6

1 reference

28 September 2017

Milicić S

7

1 reference

28 September 2017

Stalc A

8

1 reference

28 September 2017

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

431

1 reference

28 September 2017

6 Suppl 2

1 reference

28 September 2017

R233-4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02346354

28 September 2017

0 references

cites work

Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02346354

Tumour necrosis factor is a compact trimer

21 January 2018

1 reference

12 December 2020

Antitumor effect of recombinant human tumor necrosis factor-alpha analog combined with desmuramyl dipeptides LK-409 or LK-410 on sarcoma in mice

1 reference

12 December 2020

Modification of TNF-alpha pharmacokinetics in SA-1 tumor-bearing mice

1 reference

12 December 2020

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

12 December 2020

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

12 December 2020

Structure-activity studies of human tumour necrosis factors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02346354

1 reference

28 September 2017

1 reference